Mucomyst for Hepatitis C

Paused · Not applicable

Conditions studied: Hepatitis C

In brief

The study will examine the effects of treatment with N-acetylcysteine ( Mucomyst ) 1 gm twice a day for 30 dyas in 15 patients with hepatitis C. The primary outcome of interest wil be the changes in oxidant stress as measured by different oxidant stress markers level in sera. Secondary outcomes of interest will be changes in viral load of hep C and changes in liver function

Key facts

Study ID

NCT00493610

Run by

US Department of Veterans Affairs

People needed

5

Starts

2006-11-01

Expected to finish

2008-06-01

Last updated by the study team

2010-01-08

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with known hepatitis C

You may not qualify if…

• Patient on another therapy for Hep C
• Patient on dialysis
• Patient who are allergic to Mucomyst

Where it is running

• VA Medical Center, Dayton — Dayton, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.